These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5020278)

  • 1. The effect of carbamylation of Hb-S on the sickling process.
    May A; Huehns ER; Beaven GH
    Clin Sci; 1972 Apr; 42(4):20P-21P. PubMed ID: 5020278
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyanate and sickling.
    Charache S; Diederich D
    N Engl J Med; 1971 Nov; 285(20):1147. PubMed ID: 5095746
    [No Abstract]   [Full Text] [Related]  

  • 3. The clinical use of cyanate in sickling.
    Ranney HM
    N Engl J Med; 1972 Jul; 287(2):98-100. PubMed ID: 4624186
    [No Abstract]   [Full Text] [Related]  

  • 4. Urea, cyanate and sickling.
    Harris A
    N Engl J Med; 1971 Sep; 285(12):690-1. PubMed ID: 5563487
    [No Abstract]   [Full Text] [Related]  

  • 5. Carbamylation of the chains of hemoglobin S by cyanate in vitro and in vivo.
    Njikam N; Jones WM; Nigen AM; Gillette PN; Williams RC; Manning JM
    J Biol Chem; 1973 Dec; 248(23):8052-6. PubMed ID: 4752945
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of urea and cyanate on sickling in vitro.
    Segel GB; Feig SA; Mentzer WC; McCaffrey RP; Wells R; Bunn HF; Shohet SB; Nathan DG
    N Engl J Med; 1972 Jul; 287(2):59-64. PubMed ID: 5031386
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyanate as an inhibitor of red-cell sickling.
    Cerami A
    N Engl J Med; 1972 Oct; 287(16):807-12. PubMed ID: 4560520
    [No Abstract]   [Full Text] [Related]  

  • 8. The treatment of sickle-cell disease.
    Lancet; 1972 Mar; 1(7752):671-2. PubMed ID: 4125168
    [No Abstract]   [Full Text] [Related]  

  • 9. Gas chromatographic determination of the carbamylation of hemoglobin S by cyanate.
    Manning JM; Lee CK; Cerami A; Gillette PN
    J Lab Clin Med; 1973 Jun; 81(6):941-5. PubMed ID: 4710373
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhancement of filterability of sickle cells by cyanate: an effect independent of oxygen saturation.
    Wagner SM; Bishop J; Flanigan PW; Bromberg PA; Balcerzak SP
    J Lab Clin Med; 1975 Mar; 85(3):445-50. PubMed ID: 1117207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between the oxygen affinity and in vitro sickling propensity of carbamylated sickle erythrocytes.
    Diederich D
    Biochem Biophys Res Commun; 1972 Feb; 46(3):1255-61. PubMed ID: 5012168
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyanate effect on sickling.
    Charache S; Milner PF
    N Engl J Med; 1972 Dec; 287(26):1357-8. PubMed ID: 4635027
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased survival of sickle-cell erythrocytes after treatment in vitro with sodium cyanate.
    Gillette PN; Manning JM; Cerami A
    Proc Natl Acad Sci U S A; 1971 Nov; 68(11):2791-3. PubMed ID: 5288258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cyanate on sickling.
    May A; Bellingham AJ; Huehns ER; Beaven GH
    Lancet; 1972 Mar; 1(7752):658-61. PubMed ID: 4125163
    [No Abstract]   [Full Text] [Related]  

  • 15. Red cell survival of cyanate reacted sickle cells.
    Bellingham AJ; May A; Huehns ER
    Clin Sci; 1972 Apr; 42(4):21P. PubMed ID: 5020279
    [No Abstract]   [Full Text] [Related]  

  • 16. Preliminary studies of continuous extracorporeal carbamylation in the treatment of sickle cell anemia.
    Balcerzak SP; Grever MR; Sing DE; Bishop JN; Segal ML
    J Lab Clin Med; 1982 Sep; 100(3):345-55. PubMed ID: 7108349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New drugs in the treatment of sickle cell anemia.
    Freedman ML
    Am J Med Sci; 1973 May; 265(5):371-3. PubMed ID: 4576757
    [No Abstract]   [Full Text] [Related]  

  • 18. Urea, urease, cyanate, and the sickling of hemoglobin S.
    Nalbandian RM; Nichols BM; Stehouwer EJ; Camp FR
    Clin Chem; 1972 Sep; 18(9):961-4. PubMed ID: 5052097
    [No Abstract]   [Full Text] [Related]  

  • 19. The pharmacology of cyanate with a summary of its initial usage in sickle cell disease.
    Gillette PN; Lu YS; Peterson CM
    Prog Hematol; 1973; 8():181-90. PubMed ID: 4788375
    [No Abstract]   [Full Text] [Related]  

  • 20. Continuous extracorporeal chemotherapy of blood utilizing hemodialysis: potential for the treatment of sickle cell disease.
    Kjellstrand CM; Shideman JR; Eaton JW
    Trans Am Soc Artif Intern Organs; 1974; 20 B():574-8. PubMed ID: 4450307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.